Eugit Therapeutics is a biotechnology research company that develops tissue targetting drugs for therapeutic purposes.
Eugit Therapeutics has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2022.
Eugit Therapeutics's investors include Y Combinator.
Eugit Therapeutics is headquartered in San Carlos, United States.
Eugit Therapeutics is a biotechnology research company that develops tissue targetting drugs for therapeutic purposes.
Eugit Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eugit Therapeutics — Funding & Investors." VCBacked, September 8, 2022, https://www.vcbacked.co/company/eugit-therapeutics. Accessed August 13, 2026.
VCBacked. (2022). Eugit Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/eugit-therapeutics
{{cite web |title=Eugit Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/eugit-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated